SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-010322
Filing Date
2024-04-04
Accepted
2024-04-04 18:11:50
Documents
1
Period of Report
2024-04-02

Document Format Files

Seq Description Document Type Size
1 form4-04042024_100443.html 4  
1 form4-04042024_100443.xml 4 3499
  Complete submission text file 0001415889-24-010322.txt   4947
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
Grimaud Brett A. (Reporting) CIK: 0001966698 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 24824273